Skip to main content
Clinical Trials/IRCT20190325043107N42
IRCT20190325043107N42RecruitingPhase 2

Investigating the effect of dexmedetomidine in preventing delirium after esophagectomy surgery

Tabriz University of Medical Sciences0 sites80 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 2
Status
Recruiting
Enrollment
80

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 years to 65 years (—)
Sex
All

Inclusion Criteria

  • Candidate for esophagectomy surgery
  • The duration of the surgery is between three and five hours
  • Same anesthesia method for all patients

Exclusion Criteria

  • Body mass index greater than 30
  • ASA class above III
  • Heart rate less than 50 beats per minute
  • Allergy to dexmedetomidine

Investigators

Similar Trials